Claritev Gross Margin 2019-2025 | CTEV
Claritev Gross Margin Historical Data | |||
---|---|---|---|
Date | TTM Revenue | TTM Gross Profit | Gross Margin |
2025-03-31 | $0.93B | $0.69B | 74.30% |
2024-12-31 | $0.93B | $0.69B | 74.30% |
2024-09-30 | $0.94B | $0.70B | 74.20% |
2024-06-30 | $0.96B | $0.71B | 74.45% |
2024-03-31 | $0.96B | $0.72B | 74.79% |
2023-12-31 | $0.96B | $0.73B | 75.47% |
2023-09-30 | $0.96B | $0.73B | 76.12% |
2023-06-30 | $0.97B | $0.75B | 77.12% |
2023-03-31 | $1.02B | $0.81B | 79.17% |
2022-12-31 | $1.08B | $0.88B | 81.09% |
2022-09-30 | $1.14B | $0.94B | 82.75% |
2022-06-30 | $1.17B | $0.99B | 84.07% |
2022-03-31 | $1.16B | $0.98B | 84.40% |
2021-12-31 | $1.12B | $0.94B | 84.42% |
2021-09-30 | $1.07B | $0.87B | 81.19% |
2021-06-30 | $1.01B | $0.70B | 69.70% |
2021-03-31 | $0.94B | $0.63B | 66.63% |
2020-12-31 | $0.94B | $0.62B | 65.99% |
Sector | Industry | Market Cap | Revenue |
---|---|---|---|
Medical | Medical Information Systems | $0.472B | $0.931B |
Claritev Corporation is a healthcare technology, data and insights company. Claritev Corporation, formerly known as MultiPlan, is based in NEW YORK. |
Stock Name | Country | Market Cap | PE Ratio |
---|---|---|---|
Veeva Systems (VEEV) | United States | $39.174B | 54.11 |
Hims & Hers Health (HIMS) | United States | $13.701B | 142.35 |
Tempus AI (TEM) | United States | $10.751B | 0.00 |
IRhythm Technologies (IRTC) | United States | $4.508B | 0.00 |
Inspire Medical Systems (INSP) | United States | $4.426B | 69.15 |
Privia Health (PRVA) | United States | $2.989B | 204.33 |
Enovis (ENOV) | United States | $1.969B | 10.98 |
Clover Health Investments (CLOV) | United States | $1.878B | 0.00 |
Schrodinger (SDGR) | United States | $1.573B | 0.00 |
Phreesia (PHR) | United States | $1.516B | 0.00 |
Omnicell (OMCL) | United States | $1.348B | 23.78 |
Azenta (AZTA) | United States | $1.294B | 60.15 |
10x Genomics (TXG) | United States | $1.118B | 0.00 |
Fulgent Genetics (FLGT) | United States | $0.646B | 0.00 |
Butterfly Network (BFLY) | United States | $0.566B | 0.00 |
Talkspace (TALK) | United States | $0.502B | 150.00 |
Veradigm (MDRX) | United States | $0.476B | 0.00 |
Standard BioTools (LAB) | United States | $0.399B | 0.00 |
TruBridge (TBRG) | United States | $0.374B | 830.67 |
Health Catalyst (HCAT) | United States | $0.274B | 0.00 |
Nyxoah SA (NYXH) | Belgium | $0.262B | 0.00 |
SOPHiA GENETICS SA (SOPH) | Switzerland | $0.192B | 0.00 |
EUDA Health Holdings (EUDA) | Singapore | $0.144B | 0.00 |
Pulmonx (LUNG) | United States | $0.135B | 0.00 |
American Well (AMWL) | United States | $0.118B | 0.00 |
MDxHealth SA (MDXH) | Belgium | $0.102B | 0.00 |
CareCloud (CCLD) | United States | $0.090B | 3.42 |
Outset Medical (OM) | United States | $0.070B | 0.00 |
111 (YI) | China | $0.069B | 0.00 |
Retrieve Medical Holdings (RMHI) | United States | $0.059B | 0.00 |
P3 Health Partners (PIII) | United States | $0.058B | 0.00 |
HeartBeam (BEAT) | United States | $0.056B | 0.00 |
Zepp Health (ZEPP) | Netherlands | $0.039B | 0.00 |
Zhongchao (ZCMD) | China | $0.031B | 0.00 |
ImmunoPrecise Antibodies (IPA) | Canada | $0.022B | 0.00 |
Bullfrog AI Holdings (BFRG) | United States | $0.017B | 0.00 |
Precipio (PRPO) | United States | $0.014B | 0.00 |
MSP Recovery (MSPR) | United States | $0.013B | 0.00 |
Strata Skin Sciences (SSKN) | United States | $0.010B | 0.00 |
Predictive Oncology (POAI) | United States | $0.010B | 0.00 |
Streamline Health Solutions (STRM) | United States | $0.010B | 0.00 |
Movano (MOVE) | United States | $0.005B | 0.00 |
HeartSciences (HSCS) | United States | $0.005B | 0.00 |
Mobile-health Network Solutions (MNDR) | Singapore | $0.004B | 0.00 |
Tivic Health Systems (TIVC) | United States | $0.004B | 0.00 |
Healthcare Triangle (HCTI) | United States | $0.000B | 0.00 |
Future Health ESG (FHLT) | United States | $0.000B | 0.00 |